The global Artificial Intelligence Eye Screening System market was valued at US$ 243 million in 2024 and is anticipated to reach US$ 15650 million by 2031, witnessing a CAGR of 82.6% during the forecast period 2025-2031.
The artificial intelligence (AI) eye screening system market is experiencing robust growth as healthcare providers increasingly adopt advanced technologies for early detection and diagnosis of vision-related disorders. AI-powered eye screening systems combine deep learning algorithms with imaging devices to analyze retinal images, detect abnormalities, and assist ophthalmologists in diagnosing diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. With rising cases of eye disorders and increasing emphasis on preventive care, the demand for AI-driven eye screening systems is expanding globally.
Read Full Research Report: https://www.qyresearch.in/report-details/0948236/Global-Artificial-Intelligence-Eye-Screening-System-Market-Insights
What is an AI Eye Screening System?
AI eye screening systems use machine learning and deep neural networks to interpret medical imaging data from fundus cameras, optical coherence tomography (OCT) devices, and other diagnostic tools. These systems provide:
- Automated detection of eye diseases at early stages
- High accuracy and sensitivity comparable to expert ophthalmologists
- Faster analysis and reduced screening time
- Support for large-scale screening programs in hospitals and clinics
- Remote and tele-ophthalmology capabilities for underserved regions
By assisting healthcare professionals, AI eye screening systems help improve diagnosis efficiency, reduce workload, and increase patient access to timely care.
Market Drivers
Rising Prevalence of Eye Disorders
The growing incidence of diabetes, aging populations, and lifestyle-related conditions are leading to higher cases of diabetic retinopathy, glaucoma, and cataracts, driving the adoption of AI screening solutions.
Technological Advancements in AI and Imaging
Continuous improvements in deep learning, image recognition, and medical imaging devices enhance the accuracy and reliability of AI eye screening systems.
Shortage of Ophthalmologists
In many regions, the number of trained ophthalmologists is insufficient to meet demand. AI systems provide a scalable solution for mass screenings and primary healthcare centers.
Growth of Telemedicine and Remote Healthcare
AI eye screening solutions are increasingly integrated into telehealth platforms, enabling remote diagnosis and reducing barriers to eye care in rural and underserved areas.
Market Segmentation
The AI eye screening system market can be segmented by:
- Technology: Fundus photography-based AI, OCT-based AI, hybrid systems
- Application: Diabetic retinopathy, glaucoma, age-related macular degeneration, cataracts, other retinal diseases
- End User: Hospitals, eye clinics, diagnostic centers, research institutes, telemedicine providers
Diabetic retinopathy screening accounts for the largest share, given its prevalence among diabetic patients and the urgent need for early detection.
Regional Insights
- North America leads the market, driven by advanced healthcare infrastructure, supportive FDA approvals, and widespread adoption of AI in diagnostics.
- Europe is expanding steadily, supported by government-backed healthcare digitization programs and preventive screening initiatives.
- Asia-Pacific is the fastest-growing region, with large diabetic populations in China and India, increasing awareness, and expanding telehealth services.
- Latin America shows rising adoption, particularly in Brazil and Mexico, where healthcare modernization is creating opportunities.
- Middle East & Africa are emerging markets, with growing investments in AI-powered healthcare solutions and eye care programs.
Competitive Landscape
The market is dynamic, with technology companies, startups, and healthcare providers investing in AI screening solutions. Key players include:
- Google Health (Verily)
- Eyenuk, Inc.
- IDx Technologies (Digital Diagnostics)
- Topcon Corporation
- RetinAI Medical AG
- Visulytix
- Notal Vision
These companies are focusing on partnerships with hospitals, regulatory approvals, and cloud-based AI solutions to expand their global reach.
Challenges and Opportunities
Challenges:
- High cost of advanced AI screening systems
- Data privacy and regulatory compliance concerns
- Need for integration with existing healthcare workflows
Opportunities:
- Expansion of large-scale diabetic retinopathy screening programs
- Integration of AI screening with wearable eye-care devices
- Development of low-cost, portable AI-based diagnostic tools
- Increasing government support for AI adoption in healthcare
Future Outlook
The artificial intelligence eye screening system market is expected to grow rapidly as technology becomes integral to early detection and preventive eye care. Future trends will include:
- Wider adoption of cloud-based AI platforms for real-time diagnosis
- Integration of AI with tele-ophthalmology for remote care delivery
- Use of AI for predictive analytics and personalized treatment recommendations
- Development of cost-effective AI tools for mass screenings in emerging economies
As the global healthcare industry focuses on preventive care and digital health solutions, AI eye screening systems will play a crucial role in improving vision health outcomes worldwide.
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.
Contact Us:
QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - [email protected]
Web - https://www.qyresearch.in
